Target Audience: This activity is designed for neuropsychiatrists, child and general psychiatrists, adolescent psychiatrists, geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers, and other mental health professionals interested in treating patients with neuropsychiatric disorders to remission with measurement-based care.
Provided by the University of Cincinnati and Global Academy for Medical Education. The American Board of Psychiatry and Neurology has reviewed the Current Psychiatry/AACP 2019 Focus on Neuropsychiatry and has approved this program as part of a comprehensive CME program, which is mandated by the ABPN as a necessary component of maintenance of certification (MOC). The activity awards 19.0 AMA PRA Category 1 Credit(s)™, 13 AMA PRA Category 1 Credit(s)™ for the general program and 6 AMA PRA Category 1 Credit(s)™ for completing the pre-conference workshops, and 8 Self-Assessment Category 1 CME credits.
This Activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Global Academy for Medical Education.
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
The University of Cincinnati designates this Live Activity for a maximum of 19 AMA PRA Category 1 Credit(s)™ for completing this program, 13 AMA PRA Category 1 Credit(s)™ for the general program and 6 AMA PRA Category 1 Credit(s)™ for completing the pre-conference workshops. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants Credit Designation
The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Continuing Nursing Education The maximum number of hours awarded for this Continuing Nursing Education activity is 19 (13 for the general program and 6 for attending the pre-conference workshops) contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be .3 for the cannabis workshop and 2.7 for the general sessions and will be indicated on your certificate.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 19 (13 for the general program and 6 for attending the pre-conference workshops) contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined and will be indicated on your certificate.
At the conclusion of this activity, clinicians should be better able to:
- Discuss strategies to identify patients at risk for suicide and optimize suicide-preventive treatments
- Explain the stress diathesis model of suicidal behavior
- Develop a treatment prevention plan for suicidal patients based on this model
- Explain the underlying neurobiology that characterizes depressed patients at risk for suicidal behavior
- Discuss neuroimaging and potential biomarker findings for suicidal behavior
- Discuss the potential psychologic and psychiatric complications of prescription medications
- Recognize medical prescription drugs that can cause depression, anxiety, psychosis or mania as a side effect
- Discuss how all neurologic diseases are associated with psychiatric symptoms, and how all psychiatric disorders have neurologic underpinnings
- Outline the association between metabolic disorders and brain structural changes
- Delineate dimensions of psychopathology linked to metabolic disturbances
- Describe how treatments in psychiatry may facilitate or aggravate brain health through metabolic pathways
- Describe the gut microbiome-brain connection and the factors that affect it in neuropsychiatry
- Discuss the processes by which the microbiome and gut-brain axis are operative in neuropsychiatric disorders
- Describe the evidence from clinical studies regarding the efficacy of adjunctive therapies that modulate the microbiome, such as probiotics, prebiotics, and diet
- Develop a systematic approach to the evaluation of sleep disorders
- Identify the spectrum of treatment modalities for sleep disorders and integrate practice guidelines for their treatment
- Discuss the bidirectional relationship between sleep disorders and psychiatric disorders
- Understand and identify normal age-related changes in cognitive performance
- Separate concerns about cognitive changes that are caused by mood states and those that may be due to more serious problems
- Identify and discriminate between normal age-related changes, subjective memory complaints, and mild cognitive impairment
- Identify the prodromal symptoms that differentiate common dementing conditions, such as front-temporal dementia and Alzheimer disease
- Discriminate between Lewy Body Dementia (LBD) and Alzheimer disease
- Recognize the transition to dementia in Parkinson’s disease
- Understand which treatments should be avoided in LBD
- Identify pharmacologic treatments to help manage neuropsychiatric symptoms in dementing conditions
- Discuss the research on emerging treatments for depression and treatment-resistant depression
- Explain the physiological mechanism by which onabotulinum toxin injections may modulate a brain circuit that regulates mood
- Discuss current knowledge regarding the neuroanatomic and neurobiologic underpinnings of BPD
International Credit Designation
European physicians can earn their ECMEC®s by attending live events worldwide that have been granted ECMEC®s through the UESMS-EACCME procedure, and worldwide, except in Europe, that have been certified for AMA PRA Category 1 Credits™. European physicians can also earn their ECMEC®s by completing e-learning programs from providers from all over the world except in the United States, that have been granted ECMEC®s through the UEMS-EACCME procedure and from accredited providers from the United States, that have been certified for AMA PRA Category 1 Credits™.
Additionally, the following Countries and Regions have reciprocity with the ACCME:
• Royal College of Physicians and Surgeons of Canada (Canada)
• Federation of Royal Colleges of Physicians (UK)
• Bulgarian Union of Scientific Medical Societies (Bulgaria)
• French National Medical Council (France)
• Italian Federation of Scientific Medical Societies (Italy)
• National CME Commission of the Italian Ministry of Health (Italy)
• Spanish Accreditation Council for CME (Spain)
• Bavarian Chamber of Physicians (Germany)